These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 36309730)

  • 1. A high-throughput screening assay to identify inhibitory antibodies targeting alphavirus release.
    Ramjag A; Cutrone S; Lu K; Crasto C; Jin J; Bakkour S; Carrington CVF; Simmons G
    Virol J; 2022 Oct; 19(1):170. PubMed ID: 36309730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chikungunya Virus Exposure Partially Cross-Protects against Mayaro Virus Infection in Mice.
    Fumagalli MJ; de Souza WM; de Castro-Jorge LA; de Carvalho RVH; Castro ÍA; de Almeida LGN; Consonni SR; Zamboni DS; Figueiredo LTM
    J Virol; 2021 Nov; 95(23):e0112221. PubMed ID: 34549980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenoviral-Vectored Mayaro and Chikungunya Virus Vaccine Candidates Afford Partial Cross-Protection From Lethal Challenge in A129 Mouse Model.
    Campos RK; Preciado-Llanes L; Azar SR; Kim YC; Brandon O; López-Camacho C; Reyes-Sandoval A; Rossi SL
    Front Immunol; 2020; 11():591885. PubMed ID: 33224148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serological Responses in Patients Infected with Mayaro Virus and Evaluation of Cross-Protective Responses against Chikungunya Virus.
    Bopp NE; Jencks KJ; Siles C; Guevara C; Vilcarromero S; Fernández D; Halsey ES; Ampuero JS; Aguilar PV
    Am J Trop Med Hyg; 2021 Nov; 106(2):607-609. PubMed ID: 34844213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Near-germline human monoclonal antibodies neutralize and protect against multiple arthritogenic alphaviruses.
    Malonis RJ; Earnest JT; Kim AS; Angeliadis M; Holtsberg FW; Aman MJ; Jangra RK; Chandran K; Daily JP; Diamond MS; Kielian M; Lai JR
    Proc Natl Acad Sci U S A; 2021 Sep; 118(37):. PubMed ID: 34507983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Robustness of Serologic Investigations for Chikungunya and Mayaro Viruses following Coemergence.
    Fischer C; Bozza F; Merino Merino XJ; Pedroso C; de Oliveira Filho EF; Moreira-Soto A; Schwalb A; de Lamballerie X; Netto EM; Bozza PT; Sarno M; Brites C; Gotuzzo E; Talledo M; Drexler JF
    mSphere; 2020 Feb; 5(1):. PubMed ID: 32024703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Chikungunya virus immunity on Mayaro virus disease and epidemic potential.
    Webb EM; Azar SR; Haller SL; Langsjoen RM; Cuthbert CE; Ramjag AT; Luo H; Plante K; Wang T; Simmons G; Carrington CVF; Weaver SC; Rossi SL; Auguste AJ
    Sci Rep; 2019 Dec; 9(1):20399. PubMed ID: 31892710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-replicating adenovirus based Mayaro virus vaccine elicits protective immune responses and cross protects against other alphaviruses.
    Powers JM; Haese NN; Denton M; Ando T; Kreklywich C; Bonin K; Streblow CE; Kreklywich N; Smith P; Broeckel R; DeFilippis V; Morrison TE; Heise MT; Streblow DN
    PLoS Negl Trop Dis; 2021 Apr; 15(4):e0009308. PubMed ID: 33793555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Broadly Neutralizing Alphavirus Antibodies Bind an Epitope on E2 and Inhibit Entry and Egress.
    Fox JM; Long F; Edeling MA; Lin H; van Duijl-Richter MKS; Fong RH; Kahle KM; Smit JM; Jin J; Simmons G; Doranz BJ; Crowe JE; Fremont DH; Rossmann MG; Diamond MS
    Cell; 2015 Nov; 163(5):1095-1107. PubMed ID: 26553503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-Chikungunya Virus Monoclonal Antibody That Inhibits Viral Fusion and Release.
    Tumkosit U; Siripanyaphinyo U; Takeda N; Tsuji M; Maeda Y; Ruchusatsawat K; Shioda T; Mizushima H; Chetanachan P; Wongjaroen P; Matsuura Y; Tatsumi M; Tanaka A
    J Virol; 2020 Sep; 94(19):. PubMed ID: 32699087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiviral activities of niclosamide and nitazoxanide against chikungunya virus entry and transmission.
    Wang YM; Lu JW; Lin CC; Chin YF; Wu TY; Lin LI; Lai ZZ; Kuo SC; Ho YJ
    Antiviral Res; 2016 Nov; 135():81-90. PubMed ID: 27742486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infection Pattern of Mayaro Virus in Aedes aegypti (Diptera: Culicidae) and Transmission Potential of the Virus in Mixed Infections With Chikungunya Virus.
    Kantor AM; Lin J; Wang A; Thompson DC; Franz AWE
    J Med Entomol; 2019 Apr; 56(3):832-843. PubMed ID: 30668762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human Antibody Responses to Emerging Mayaro Virus and Cocirculating Alphavirus Infections Examined by Using Structural Proteins from Nine New and Old World Lineages.
    Smith JL; Pugh CL; Cisney ED; Keasey SL; Guevara C; Ampuero JS; Comach G; Gomez D; Ochoa-Diaz M; Hontz RD; Ulrich RG
    mSphere; 2018; 3(2):. PubMed ID: 29577083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of an Enzyme-Linked Immunosorbent Assay To Detect Antibodies Targeting Recombinant Envelope Protein 2 of Mayaro Virus.
    Fumagalli MJ; de Souza WM; Romeiro MF; de Souza Costa MC; Slhessarenko RD; Figueiredo LTM
    J Clin Microbiol; 2019 May; 57(5):. PubMed ID: 30787146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging alphaviruses in the Americas: Chikungunya and Mayaro.
    Figueiredo ML; Figueiredo LT
    Rev Soc Bras Med Trop; 2014; 47(6):677-83. PubMed ID: 25626645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a Sensitive Detection Method for Alphaviruses and Its Use as a Virus Neutralization Assay.
    Schmidt C; Perkovic M; Schnierle BS
    Viruses; 2021 Jun; 13(7):. PubMed ID: 34206519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel Mutations in nsP2 Abolish Chikungunya Virus-Induced Transcriptional Shutoff and Make the Virus Less Cytopathic without Affecting Its Replication Rates.
    Akhrymuk I; Lukash T; Frolov I; Frolova EI
    J Virol; 2019 Feb; 93(4):. PubMed ID: 30487275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inactivation and Removal of Chikungunya Virus and Mayaro Virus from Plasma-derived Medicinal Products.
    Yue C; Teitz S; Miyabashi T; Boller K; Lewis-Ximenez LL; Baylis SA; Blümel J
    Viruses; 2019 Mar; 11(3):. PubMed ID: 30866548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GloPID-R report on Chikungunya, O'nyong-nyong and Mayaro virus, part I: Biological diagnostics.
    Pezzi L; Reusken CB; Weaver SC; Drexler JF; Busch M; LaBeaud AD; Diamond MS; Vasilakis N; Drebot MA; Siqueira AM; Ribeiro GS; Kohl A; Lecuit M; Ng LFP; Gallian P; de Lamballerie X;
    Antiviral Res; 2019 Jun; 166():66-81. PubMed ID: 30905821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutralizing Antibodies Inhibit Chikungunya Virus Budding at the Plasma Membrane.
    Jin J; Galaz-Montoya JG; Sherman MB; Sun SY; Goldsmith CS; O'Toole ET; Ackerman L; Carlson LA; Weaver SC; Chiu W; Simmons G
    Cell Host Microbe; 2018 Sep; 24(3):417-428.e5. PubMed ID: 30146390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.